Iridex (IRIX) Cash from Operations Growth (5y) (2016 - 2026)
Iridex (IRIX) Cash from Operations Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Iridex | 13.34 Mn | 8.66 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -16.14% |
| Sep 27, 2025 | -36.99% |
| Jun 28, 2025 | 27.53% |
| Mar 29, 2025 | 4.59% |
| Dec 28, 2024 | -45.63% |
| Sep 28, 2024 | -3.70% |
| Jun 29, 2024 | 0.56% |
| Mar 30, 2024 | 15.37% |
| Dec 30, 2023 | 13.75% |
| Sep 30, 2023 | 9.41% |
| Jul 1, 2023 | 13.28% |
| Apr 1, 2023 | -0.84% |
| Dec 31, 2022 | -11.30% |
| Oct 1, 2022 | -2.24% |
| Jul 2, 2022 | -37.66% |
| Apr 2, 2022 | -14.93% |
| Jan 1, 2022 | 103.82% |
| Apr 3, 2021 | 86.38% |
| Mar 28, 2020 | -34.21% |
| Sep 28, 2019 | -32.42% |